NOTICE OF INTENT TO SOLE SOURCE: Center for Disease Control and Prevention (CDC), The National Center for Environmental Health (NCEH), Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH), plans to procure on a sole source basis a quantity of 50 of the brand name Perfinity Workstation Trypsin Columns from Perfinity Biosciences, West Lafayette, IN 47906 in order to satisfy the Agency's requirement. This acquisition will be processed under Federal Acquisition Regulation (FAR) Subpart 12, Acquisition for Commercial Items and will be made in accordance with simplified acquisition procedures as stated in FAR part 13.106-1(b)(1). The North American Industry Classification System code is 325199, All Other Basic Organic Chemical Manufacturing, and the business size standard is 1,250 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Delivery shall be within sixty (60) days after award.

A sole source acquisition is justified because Perfinity Biosciences is the only source that will meet the Agency's technical requirement. The trypsin columns are designed and optimized specifically to accommodate the existing on-line digestion and LC-MS/MS systems. Only Perfinity Biosciences makes the trypsin columns requested in the formats and materials that will be stable up-to 50 C-degree temperature and high pressure to be compatible with the fully automated on-line system. The material requested is proprietary in nature.

CDC intends to negotiate this requirement with Perfinity Biosciences under the authority of FAR 13.106-1(b) (1), Only One Responsible Source, and 41 U.S.C. 253(c) (1). Perfinity Biosciences is the only source available to provide these services and meet the Agency's critical requirement. This notice of intent is not a request for competitive proposals or quotations. A determination to compete this procurement based on responses to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a capability statement demonstrating their abilities to meet this requirement as described above. All responses should be received by June 6, 2017, at 10AM, Eastern Standard Time (EST). All responses must be in writing and can be sent via email to [email protected] with the reference number 2017-Q-66836 in the subject line. No telephone calls will be accepted.

 

Bid Protests Not Available